Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT00294567
Eligibility Criteria:
Inclusion Criteria:
* Age: Between 20 and 79 years (at the time of giving informed consent).
* Sex: Either sex.
* Admission status: Outpatients.
* Patients requiring treatment for hypertension according to the JSH 2004 hypertension therapy guidelines before beginning this study
* Patients who have not used any calcium antagonists for at least 4 weeks before the beginning of this study.
* Patients who are scheduled to undergo elective PCI.
Exclusion Criteria:
* Patients with acute coronary syndrome (ACS).
* Patients who have experienced Q-wave myocardial infarction within 4 weeks before beginning this study.
* Patients with renal dysfunction (serum creatinine \>2.0 mg/dL).
* Patients in whom PCI is unsuccessful.
* Patients with cardiogenic shock.
* Patients with moderate or severe congestive heart failure.
* Patients with 50% or more stenosis of the main trunk of the left coronary artery.
* Patients with other problems whom the investigator considers unsuitable for this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
79 Years
Study:
NCT00294567
Study Brief:
Protocol Section:
NCT00294567